ga16 | kuching | healthcare meetings

Healthcare Meetings Sector: Where does it Hurt this Year?

55th ICCA Congress

Why are we here?• Pain Points

• Regulations and codes



• Cures & Sticking Plasters• Reshaping of medical meetings• Take part in the evolution – short & long term



• Cures & Sticking Plasters• Reshaping of medical meetings• Take part in the evolution – short & long term

• Outcomes• You will have clarity and new ideas• Identify key ideas for distribution by ICCA

Who is in the Room?

Session FlowBrief presentations by 2 speakers (10 minutes each)

Hold questions until the end

Discussion at your table

(20 minutes)Identify new

ideas

What solutions can be

implemented in your organization

Record ideas/solutions on flip charts

Identify 1-2 key ideas from each

table

Repeat 2x – Total of 6 presentations and 3 table discussions

Closing discussion – identify key ideas, conclusions, recommendations

Areas of Discussion

• Compliance is here to stay – how to work within the restrictionsRound One

• How can venues and destinations strengthen their partnership with medical meetings

Round Two

• The changing role of medical associations and societies

Round Three

Christine SainvilEthical Med Tech

Compliance is here to stay – how to work within the restrictios

www.medtecheurope.org

MedTech EuropeCode of Ethical Business Practice

Christine Sainvil, Compliance Officer 55th ICCA Congress, KuchingNovember 15th, 2016


What is MedTech Europe?

New MedTech Europe Code

What arethe main

changes?

New MedTech Europe Code

How could the

Code affect Healthcare

Events Organisers?

MedTech Europe

Initiative

Trusted Partner initiative

Structure of the presentation

www.medtecheurope.org 1

WHAT IS MEDTECH EUROPE?Part 1


MedTech Europe is an Alliance of European medical technology industry associations

Mission to make value-based, innovative medical technology available to

more people, while supporting the transformation of healthcare systems

onto a sustainable path

Membership 112 Corporate Members;

49 National Associations and Associates National Associations


HCPs are trained on how to use technologies

The industry liaises regularly with HCPs to ensure that the technologies are updated and maintained

HCPs actively participate in the research to develop new technologies

This close collaboration is key to develop innovative technologies to treat patients

MedTech industryHCPs

The MedTech industry and HCPs collaborate closely throughout several stages of the development and use of medical technologies.

MedTech’s major differences with Pharma


WHAT ARE THE MAIN CHANGES?Part 2


Six biggest changes

Phasing out direct sponsorship

Common chapter on general criteria

for events Transparency of

educational grants

New chapter on demonstration

products and samplesCommon independent

enforcement mechanismAgreed

definitions


Companies select individual HCPs and financially support their participation to Third Party Organised Events.

Companies provide educational grants to hospitals, medical societies and other third parties to support genuine medical education.

“Direct sponsorship”

Such financial support typically covers some or all of the travel, lodging and registration costs of the HCP.

These include educational grants provided to support HCP participation to Third Party Organised Event. HCPs are selected by the receiver of the grant.

“Educational grants”

Two types of industry support to Third Party Organised Events


Transposition of the new code

Phasing out direct sponsorship

+Collecting data for disclosure

Timelines

2016 2017 2018

Starting to disclose

Direct Sponsorship

banned

New Codecomes into

force

19


CODE: IMPACT ON HEALTHCARE EVENTS ORGANISATIONS

Part 3


Grants will be publicly disclosed, ensuring increased transparency of the funds allocated to medical education

Conferences will still need to comply with specific requirements and with the Conference Vetting System

Grants can only be provided to legal entities but never individuals and will require a written contract & other related documentation

Companies will be able to define the type of recipients which should be eligible for the grant but not individual recipients

Companies must have an internal & independent process based on objective criteria to assess the grant requests

How the rules for educational grants will change?


Definition of Educational Grants?

• Provision of funding, products or other in kind support to an HCO by or on behalf of a

Company on a restricted basis for use solely for the support and the advancement of genuine

medical education of HCPs, patients and/or the public on clinical, scientific and/or healthcare

topics relevant to the therapeutic areas in which the Company is interested and/or involved (i.

e. sponsorships , Fellowships, Grants for public awareness campaigns)

Publication where?

Unique European website (N.B.: if national transparency rules in place, no double reporting).

By whom? Reporting by companies.

When? 2018 (of 2017 data)

1. Public disclosure of Educational Grants

17


No/minor changes of the existing criteria – CVS* needs to approve congresses before any support provision

• Image & Reputation: How would that support be perceived by the public/authorities?

• Scientific programme directly related to the medical practice of HCPs

- No social, sporting and/or leisure activities or other forms of entertainment

• Location and venue should be in or near a city or town which is a recognised scientific or business centre

- No luxurious, tourist/holiday-oriented, entertainment location & venues

- No events during touristic season

- No locations that are hard to access or that are not centrally located

• Guest packages: No facilitation or payment for meals, travel, accommodation or other expenses for guests of HCPs

• Reasonable hospitality and travel tied in to the duration of the event

- No top category or luxury hotels for accommodation

- No luxurious dinners

- Only economy or standard class for travel by plane unless the flight time is longer than 5 hours

• Communication support.

* CVS = Conference Vetting System – more on www.EthicalMedTech.eu

2. Compliance with Events requirements, incl. CVS

17

http://www.ethicalmedtech.org/


Events

Scientific Programme

Geographic Location and

Venue

GuestsPackages

Hospitality

Accommodation

CommunicationSupport

The Conference Vetting System remains

14


• Grants can only be given to an HCO (never an HCP)

- The payment (or provision of other support) always be made out in the name of the

HCO

- Grants cannot be provided in response to requests made by HCPs unless the HCP

is an employee or officer of the qualifying organisation or entity and submits the

request in writing on behalf of the HCO.

• The grant request needs to be done in writing to the Company, and may include:

- information on the HCO (e.g. legal status)

- If previous grants: Information how previous funds have been used in accordance to

the terms and conditions of the previous Grant agreement.

• Written Grant agreement signed by both parties before provision of any funds.

• Records of everything should be kept.

3. Documentation principle

17


Principle:

• Companies will be able to define in the Grant agreement with the HCO, the type of

“final” recipients/beneficiaries (e.g. Romanian ostomy nurses) which should be

eligible for the grant but not individual recipients/beneficiaries (e.g. Dr. X).

Practically:

• HCOs, in particular scientific societies, and PCOs will need to consider how to

proceed for this selection

• Some HCOs reported that they constituted a database are considering adding

objective criteria such as submission of an abstract.

4. Identification of the final recipients of the Grant

17


Principle:

• Companies must have an internal & independent (i.e. not primarily sales-driven)

process based on objective criteria to assess the grant requests.

Practically:

• The HCO can make a written request, containing sufficient information to permit an

objective evaluation of the request to be carried out by the Company, to a

Company.

5. Independent process within the companies

17


MEDTECH EUROPE “TRUSTED PARTNER” INITIATIVE

Part 4


General concerns

- Medical education of HCPs at stake – vulnerable HCPs/countries

- Concern that industry funding to support education/events may decrease

Technical concerns

- Which HCPs to invite? Which database? What selection process? How to reach the HCPs?

- Travel & accommodation management – infrastructure/HR – associated costs

- Timing alignment (planning vs. funding)

Key concerns of Conference Organisers

17


Trusted Partner Initiative

Expression of interest from conference organising company to

MedTech Europe

Online training on MedTech

Europe Code+

Online assessment

Charter signature

+

Accreditation of Trusted

Partner status


Supporting tools

Leaflet for HCOs Leaflet for HCPs

These tools are available atwww.medtecheurope.org

And in the Member’s Area corner

http://www.medtecheurope.org/


FOR MORE INFORMATION

Christine SainvilCompliance Officer

[email protected]

Pablo Rojas AbadLegal & Compliance Assistant

[email protected]

61

Clarisse AilletMedical Education consultant

[email protected]

mailto:[email protected]




Martin JensenIPCAA

Compliance is here to stay – how to work within the restrictios

ICCA World CongressKuching, November 15th 2016

Martin N JensenIPCAA Co-PresidentHead Global Congress & Event Management &

Interim Head of Global Customer Interaction Management H. Lundbeck

Disclousre

• No honorarium paid

• Flights & Accommodation covered by ICCA & IPCAA

Please note that the following slides ‘are the personal opinion of the speaker basing on his observation and experience as professional and IPCAA Co-President.

Mission

‘To ensure the most beneficial outcome for all parties involved in medical congresses, through the development of common and consistent congress policies and through recognised partnerships with medical societies.’

Pharmaceutical IndustryChanging Landscape

Public Perception and scrutiny has led to focus on Trust and Transparency

Significant Industry Engagement - US Sunshine Act

- EFPIA Data Transparency Initiative

- Specific Country Regulations e.g. Japan, Australia

Area of focus: Destination Location & Venue Structure Scientific Program Transfer of Value

New Standard Compliance Master 37

Medical Congresses

Scientific Program

Symposia Exhibition

Scientific Poster Other Scientific Engagements

Social Program Support via

Registration Fee

Excursions (Support)

Partner Program (support)

Gifts and Gadgets


Medical Congresses

Scientific Program

Symposia Exhibition

Scientific Poster Other Scientific Engagements

No Social Program Support via

Registration Fee

No Excursions (Support)

No Partner Program (support)

Gifts and Gadgets

Provision


EFPIA

European Federation of Pharmaceutical Industries and Associations

• Represents the pharmaceutical industry operating in Europe

- 33 National Associations- 40 leading companies- Including Vaccines Europe and- European Biopharmaceutical Enterprises

• Members are bound by a Code of Practice

• Maintains e4ethics assessment platform• Disclosure Code launched 2014

- Data collection 2015- Reporting in 2016- 33 different reporting requirements


Leadershp Statement


General statements of industry leaders CEOs of 23 global companies

• Full respect for the role that EU legislation plays in regulating interactions between pharmaceutical companies and healthcare professionals.

• Commitment to working towards greater transparency, accountability and ethical behavior within an industry framework of self-regulation.

• Adherence to EFPIA Codes establishing standards for appropriate behavior in companies relations with healthcare professionals and patient organizations is essential – breaches should not be tolerated.

Similarities

• HCP interaction• Applies to sponsoring delegates

• Although EFPIA relates to all of article 9 of it guidelines including sponsorship activities

• EU (33 membership states) only• Review of programs, venues,

destinations, hospitality & accompanying persons

Differences

• Spouse program• Recommendation vs must follow

review process:• EUCOMED done by conference

owners• e4Ethics done by EFPIA

• Direct Sponsorship– EFPIA Allows post 2018– EUCOMED / MedTech does not

EFPIA vs EUCOMED / MedTech

HCP’s Learning Journey & Impact of Disclousre

Key points from research survey of HCP vs reputation survey & focus group conducted by Lundbeck

General satisfaction with learning resources

The average response for the current options available to you in terms of clinical disease information online was 7.1%

39% of HCPs stated that they have not had a positive delegate experience at many of the meetings they have attended

Face-to-face engagement

What needs to improve? HCP networks for virtual attendees and pharma’s use of social media for those attending

Offline engagement with industry such as poster sessions, exhibiting booth and networking preferable to digital/social

Attending educational sessions, attending sponsored symposia and browsing poster sessions were the top three preferred methods of learning at the event

Education (47%), Face-to-face networking/meetings (24%) and Learning about new technologies (12%) were the top three reasons

Top two benefits to attending were both networking – one with experts in their field, the other with peers

Types of content offered and use of mobile technology

Learning experience preferences

Following virtually

Co-creation57% would consider authoring a medical article

The most preferred method for doing this was Downloadable materials (such as presentations/slides) from medical society websites, the second was live virtual broadcasts and thirdly accessing content from pharma websites

61% find it difficult to attend meetings and would like information to be available online and in real time, so that they can access it remotely, around their practice commitments.

85% of HCPs would like to have greater input into the agenda

Disclosure Impact

Societies and PCO’s needs to ready to be disclosed

Industry will support HCO’s rather than HCP’s -however not to work around disclosure code

Regional difference in collaboration between HCO’s & HCP

Societies must become more competitive in its offerings to attract the right delegates, as delegates will be more selective

Delegates will go for fewer congresses and either go for one large with many areas of interest or few small with specialist – but not both and not mid size

Self-employed HCP’s tend to stay shorter at congress than those employed by an HCO

Some HCP’s will not accept sponsorship – or at least for a whileEducation must continue

Industry is working in greater details with societies to attract a different type of delegate (the new customer) on demand when required, both online and on site - 24/7/365

Industry is working with societies to change the behavior of the delegates onsite (more scientific material vs promotional) i.e. moving from marketing driven approach to Scientific Education

Questions?


AMEX:

https://www.amexglobalbusinesstravel.com/research-insights/

ASHFIELD:

https://www.ashfieldhealthcare.com/gb/post/the-changing-face-of-physician-needs/

Links to Surveys






Co-Presidents:Martin N. JensenChristian-Claus Roth

Executive Officer:Rita Gutzwiller

IPCAA SecretariatPO Box 182CH-4013 BaselSwitzerland

Tel: +41 61 821 [email protected]

Thank you for your attention!


ICCA World CongressKuching, November 15th 2016

Table DiscussionHow does this impact

your world

What are your 2 main challenges with the

industry codes

What solutions can be implemented in your

organization


Identify 1-2 key ideas from each table

And please share the talk time

Christoph TessmarBarcelona Convention

BureauHow can venues & destinations strengthen their

partnership with medical meetings

The Role of the Barcelona Convention Bureau

Related to Compliance

38% Medical & Pharma Industry

S B E R C J H Y U I M R A J H G V F R U Z

I K L J N T Y T R A I N I N G D C B A H D

O R G A N I Z A T I O N E X R G T I J N B

C V F R G H N J Z L E A D E R S H I P L K

O H K K N O W L E D G E S C X A W Q N U K

N H Y I K L P C D F F C A W E Q X Z L P H

Y J I U B F R E C O M M E N D A T I O N M

L B C R Y A F N U K P Q D C Z A R E C E J

V Y T J B B N H D S E W C G T H M D F F R

L J K I A A C W P I Y V N H D L C O E S A

Farmaindustria: The Spanish

Code of Practice

Members of the Barcelona

Convention Bureau

Rates alignment with the Codes

Barcelona Convention Bureau

Course of Action

Meetings between Associations & Farmaindustria

Thank You!

Christoph TessmarDirector Barcelona Convention Bureau

[email protected]

Lisa SullivanIn Vivo Communications

& WentzMiller Global Services

How can venues & destinations strengthen their partnership with medical meetings

International Congress and Convention Association.

My coverage


Trends in CME/CPD

Accredited CME/CPD requirements are on the rise in emerging markets

India’s states are mandating CME and there is a push towards national structure

China now has mandatory CME/CPD and may start penalties for non-compliance

Indonesia instituted a sophisticated CPD programAsia Healthcare Meetings Forum calls for an

improved focus on CME/CPD accreditation US Grant based sponsorship of CME/CPD just

starting to venture into Australia/AsiaCommercial support spending is down for

CME/CPD as well as exhibits


Trends

More creativity needed from medical societies to maintain attendance with less industry support

Millennials emphasize online, social media to learn and interact with patients

CME/CPD meetings structure will force venues to be more flexible/workshops/interactive


Survey of healthcare managers Asia Healthcare Meetings Forum Oct 2014

How do you feel about the future of the healthcare sector meetings?



Do you think healthcare/lifescience sponsorship of HCP attendees to medical congresses is…? [Med society-Healthcare company-Agency]



To what extent will exhibit booths continue to be an important part of scientific exchange? [Med society-Healthcare company-Agency]


Should venue managers worry?

YesOver time, doctors will migrate to more personalized learning, fewer large meetings

Possible solutions

Flexible use of space/ smaller sessions, workshops

Incorporate technology to personalize learning onsite with social interaction

Don’t create roadblocks to providers using your space (e.g. inability to use external AV companies)

Help providers market more extensively especially accredited CME/CPD

Table DiscussionIdentify new ideas

What solutions can be implemented in your

organization




Annalisa PonchiaEuropean Society for Organ

TransplantThe changing role of medical associations & societies

52nd ICCA Congress


Twitter: #ICCA13

“Where does it hurt?”Can international healthcare meetings evolve swiftly enough to meet the pressures to become more transparent, more educationally effective, and still remain financially viable?

Annalisa Ponchia BaccaraExecutive OfficerEuropean Society for Organ Transplantation


Twitter: #ICCA13

ESOT main agenda is delivering Education Medical Education cannot be delivered without the necessary financial supportPharma Industry has played a major role financing Medical Education, sometime conflicting with branded education platforms and meetings

Reduced sponsorship have forced our Organization to reshape the business model and to redefine formats and programs

Medical Societies have now the opportunity to bridge the gap that compliance necessities could create

The rationale

Jan SamynSeauton International

The changing role of medical associations & societies

Table DiscussionWhat are we waiting

for?

What can you do?




Key Ideas

Changing role of medical

associations

Venues & destinations as partners

Working within

restrictions of compliance

Thanks to our speakers!• Christine Sainvil• Martin Jensen• Christoph Tessmar• Lisa Sullivan• Annalisa Ponchia• Jan Samyn

Healthcare Meetings Sector: Where does it Hurt this Year?

Thank you for attending!

55th ICCA Congress